Calysta
Menlo Park, US · Delaware corporation · 60 employees on LinkedIn · 11 known investors
Find your way into Calysta
288 people in our graph share verified history with the Calysta team — schools, employers, funds. One of them is your warm intro.
Bertie Aykroydunlockedknows Alan Shaw · together at Durham University
×10knows the team · via Durham University
knows the team · via Teesside University
Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food. The company operates in cellular agriculture and food technology, with a FeedKind production plant in China run through its Calysseo partnership.
Founders & leadership
AS
Alan Shaw, Ph.D.Co-founder
AS
Alan ShawinPresident, Chief Executive Officer and Co-FounderAlan Shaw is President and Chief Executive Officer of Calysta, which produces sustainable protein ingredients through fermentation technology. He previously founded and led Codexis, a biotechnology company focused on bio-based processes, and has held executive roles in the chemical and biotechnology industries.
LG
Lori GiverinChief Science and Sustainability Officer
CB
Craig Barratt, Ph.D.Named on SEC filing
DH
David HayesNamed on SEC filing
SS
Suan Swee TanNamed on SEC filing
RT
Rich TorresNamed on SEC filing
Board
MV
Investors · 11
Aqua SparkUtrecht
Baruch Future VenturesSan Francisco · $100K – $1M
Celesta CapitalMenlo Park · $5M – $20M
Celesta CapitalSan Francisco
Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M
SQN Venture Partners, LLCCharleston
bp venturesreported · 2 sourcesLondon · $1M – $10M
Pangaea VenturesreportedScottsdale
WTIreportedPortola Valley
Also in the syndicate · 2
AdisseoAquaSpark
Funding
SEC filings, press & company announcements$84.2M disclosed across 2 rounds · 2019–2021
- $39MSeries D-1 funding roundSep 2021 · 2 sources
bp ventures (lead), Adisseo, AquaSpark, WTI
Source ↗
▶$45.2MraisedOct 2019 · 18 investors · BiotechnologyRule 506(b)
▶$45.2MraisedOct 2019 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan Shaw, Ph.D.Executive Officer, Director
- Craig Barratt, Ph.D.Director
- David HayesDirector
- Suan Swee TanDirector
- Mike VelingsDirector
- Rich TorresDirector
- Offering amount
- $120M
- Amount sold
- $45.2M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Calysta went on to found or lead other companies.
Competitors · 3
by search overlap
Fortis Life Sciences6 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Alcresta6 shared keywordsAlcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.
Newswise5 shared keywordsNewswise is a news distribution platform and press release service that connects journalists, public relations professionals, and the public with research news and expert sources across medical, science, life, and business sectors.
Companies competing with Calysta for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Calysta do?
- Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food. The company operates in cellular agriculture and food technology, with a FeedKind production plant in China run through its Calysseo partnership.
- Who founded Calysta?
- Calysta was founded by Alan Shaw, Ph.D., Alan Shaw.
- Who are Calysta's investors?
- Calysta's investors include Aqua Spark, Baruch Future Ventures, Celesta Capital, Celesta Capital, Pangaea Ventures Us Inc., SQN Venture Partners, LLC, bp ventures, Pangaea Ventures and 1 more.
- How much funding has Calysta raised?
- Calysta has disclosed $84.2M raised across 2 rounds.
- Where is Calysta headquartered?
- Calysta is headquartered in Menlo Park, US.